tazobactam has been researched along with Bronchiectasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz-Serrano, V; Amaro, R; Bueno-Freire, L; Cabrera, R; Fernández-Barat, L; López-Aladid, R; Muñoz, L; Oscanoa, P; Torres, A; Vázquez, N; Vila, J | 1 |
1 other study(ies) available for tazobactam and Bronchiectasis
| Article | Year |
|---|---|
Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bronchiectasis; Ceftazidime; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |